Mouse macrophages primed with alendronate down-regulate monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) production in response to Toll-like receptor (TLR) 2 and TLR4 agonist via Smad3 activation-Reference-Cited by-同舟云学术

Mouse macrophages primed with alendronate down-regulate monocyte chemoattractant protein-1 (MCP-1) and macrophage inflammatory protein-1α (MIP-1α) production in response to Toll-like receptor (TLR) 2 and TLR4 agonist via Smad3 activation

Published:2009-08 Issue:9 Volume:9 Page:1115-1121
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Masuda Takahiro,Deng Xue,Tamai Riyoko

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference54 articles.

1. Bisphosphonates, pharmacology and the use in the treatment of tumour induced hypercalcaemia and metastatic bone diseases;Fleisch;Drugs,1991

2. Bisphosphonates as anticancer drugs;Mundy;Expert Opin Investig Drugs,1999

3. Cellular and molecular mechanisms of action of bisphosphonates;Rogers;Cancer,2000

4. Toward new horizons: the future of bisphosphonates therapy;Lipton;Oncologist,2004

5. The acute phase response after bisphosphonate administration;Adami;Calcif Tissue Int,1987

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Az osteoporosis antirezorptív kezelésének biológiai alapjai és az állcsontok antirezorptív kezelés okozta osteonecrosisa;Fogorvosi Szemle;2024-03-14

2. Local delivery of hydrogel encapsulated vascular endothelial growth factor for the prevention of medication-related osteonecrosis of the jaw;Scientific Reports;2021-12

3. Alendronate Augments Lipid A–Induced IL-1α Release via Activation of ASC but Not Caspase-11;Inflammation;2021-06-02

4. Molecular Targeted Therapy for the Bone Loss Secondary to Pyogenic Spondylodiscitis Using Medications for Osteoporosis: A Literature Review;International Journal of Molecular Sciences;2021-04-24

5. Etidronate down-regulates Toll-like receptor 2 ligand-induced chemokine production by inhibiting MyD88 expression and NF-κB activation;Immunopharmacology and Immunotoxicology;2020-11-29